Hepatitis B — India

A birth dose in the universal immunisation programme, and an enormous number of undiagnosed carriers.

Illustration: Hepatitis B — India

The legal framework

India introduced hepatitis B into its universal immunisation programme nationwide in 2011, with a birth dose for institutional deliveries followed by the combined vaccine. Prevalence is intermediate, but given the population the absolute number of chronic carriers is among the largest in the world, and the overwhelming majority are undiagnosed.

India introduced hepatitis B into the universal immunisation programme nationwide in 2011, with a birth dose for institutional deliveries. The birth dose is the weak point: a large share of births still occurs without it being given within twenty-four hours, and that is where chronic infection continues to be created. Prevalence in the general population is intermediate.

Key points

Birth dosePart of the universal immunisation programme since 2011, for institutional deliveries
Home birthsA gap: the birth dose is frequently missed
Antenatal screeningPart of routine antenatal care in the national programme
PrevalenceIntermediate, but very large in absolute numbers
DiagnosisThe great majority of carriers are undiagnosed
TreatmentFree antiviral treatment through the national viral hepatitis programme
Unsafe injectionsA documented contributor to transmission

In practice

Cost and coverage

Vaccination and, through the national viral hepatitis programme, testing and treatment are free.

Where to go

Worth knowing

The national programme provides free testing and free antiviral treatment. Many people pay privately because they do not know it exists.

Frequently asked questions

Is the birth dose given in India?

It is part of the programme for institutional deliveries, but coverage within the recommended twenty-four hours is incomplete, particularly for home births and in some states. If you are giving birth, ask explicitly for the birth dose — do not assume it will be given automatically.

Why does the birth dose matter so much?

Because transmission from mother to baby at birth is the route most likely to produce a lifelong chronic infection — an infant infected at birth has a very high chance of never clearing the virus, whereas an adult usually does. A vaccine dose within twenty-four hours of birth, with immunoglobulin where the mother is positive, prevents this in the great majority of cases.

Official sources and links

← All countries Hepatitis B →

Page checked in September 2026. The instruments cited can change: if in doubt, confirm with the official source given.

Locate this page in the site map

A question, a correction, a suggestion? Write to us.